11 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents ... #Medications #Pharmacology ... #Dosing #Dosing ... Renal #Impairment #CKD ... #Table #GFR #Hypoglycemics
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
Tobacco Cessation Treatment ... , Varenicline (tablet ... release (SR) (tablet ... ) #Pharmacology ... #Agents #Dosing
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... adults, <3g in CKD ... avoid NSAIDs if CKD ... • Neuropathic agents ... #agents #internship
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
patients with CKD ... phosphate binding agents ... since they are not able ... Purposes Only* #CKD ... #Pharmacology #
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... Potential Treatment ... Agents for Treatment ... infection Episode #Pharmacology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology # ... treatment #medications ... #table #pharmacotherapy ... hematology #warfarin #dosing
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... MDRTB #management #Treatment ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
Potential Treatment ... Agents for Treatment ... ClostridiumDifficile #options #treatment ... #management #pharmacology ... #idsa #table
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... Please refer to the table ... Guidelines for dosing ... Tuberculosis #TB #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommended Dosages of Antimicrobial Agents Administered by the Intraventricular Route
Amikacin - 5–50 mg
Amphotericin B -
IDSA Recommended ... Antimicrobial Agents ... #pharmacology # ... ventriculitis #table ... #idsa